A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma

Clinical trial NCT02014142 · COMPLETED

Trial details

NCT number: NCT02014142
Sponsor: Mati Therapeutics Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ocular Hypertension Open-Angle Glaucoma

Start date: 2013-12-01
Primary completion: 2016-12-01
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.